tm logo
SCLERALENS
Live/Registered
REGISTERED

on 04 Oct 2022

Last Applicant/ Owned by

17721 59TH AVENUE NE

ARLINGTON

WA

98223

Serial Number

90340677 filed on 24th Nov 2020

Registration Number

6861931 registered on 04th Oct 2022

in the Principal Register

Correspondent Address

Shannon M. Jost

STOKES LAWRENCE, P.S.

1420 FIFTH AVENUE, SUITE 3000

SEATTLE WA 98101

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"SCLERA LENS"

SCLERALENS

The mark consists of the text 'SCLERALENS' in stylized font positioned below two stacked curved lines of different lengths, the lower and shorter of which is wavy, suggesting a stylized eye surface and contact lens. Contact lenses SCLERA LENS "SCLERA LENS"

Classification Information


Class [009]
Computer & Software Products & Electrical & Scientific Products


Contact lenses


First Use Date in General

01st Dec 2020

First Use Date in Commerce

01st Dec 2020

Mark Details


Serial Number

No 90340677

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 58973-207

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

16.03.08 -

Monocles and optical or spectacle lenses

26.17.09 -

Curved line(s), band(s) or bar(s)

Description of Design Search

The mark consists of the text 'SCLERALENS' in stylized font positioned below two stacked curved lines of different lengths, the lower and shorter of which is wavy, suggesting a stylized eye surface and contact lens.

Legal History


Show more

Status DateAction Taken
04th Oct 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
04th Oct 2022REGISTERED-PRINCIPAL REGISTER
19th Jul 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19th Jul 2022PUBLISHED FOR OPPOSITION
29th Jun 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13th Jun 2022APPROVED FOR PUB - PRINCIPAL REGISTER
14th May 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
13th May 2022USE AMENDMENT ACCEPTED
11th May 2022AMENDMENT TO USE PROCESSING COMPLETE
11th May 2022USE AMENDMENT FILED